Blood Conservation in Cardiac Surgery: Let's Get Restrictive

Seminars in Thoracic and Cardiovascular Surgery

Volumn 22, Issue 2, 2010, Pages 121-126

  Varghese, Robin ^a   Myers, M Lee ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Blood; Cardiac surgery; Critical care; Hemoglobin; Transfusions

Indexed keywords

ACETYLSALICYLIC ACID; AMINOCAPROIC ACID; APROTININ; CLOPIDOGREL; HEMOGLOBIN; HEPARIN; RECOMBINANT ERYTHROPOIETIN; TRANEXAMIC ACID;

ANEMIA; ARTICLE; BLEEDING DISORDER; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL PRACTICE; CONTINUING EDUCATION; DRUG WITHDRAWAL; ERYTHROCYTE TRANSFUSION; HEART SURGERY; HEMATOCRIT; HEMODILUTION; HUMAN; HYPERTENSION; JEHOVAH'S WITNESS; PATIENT SAFETY; PEROPERATIVE CARE; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; RELIGION; SURGICAL MORTALITY; SURGICAL PATIENT; TREATMENT REFUSAL; VEIN THROMBOSIS;

BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; EVIDENCE-BASED MEDICINE; HUMANS; INTRAOPERATIVE CARE; PHYSICIAN'S PRACTICE PATTERNS; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINES AS TOPIC; PREOPERATIVE CARE; RISK ASSESSMENT; RISK FACTORS;

EID: 78449304104     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2010.09.010     Document Type: Article

References (40)

1. Chiavetta J.A., Herst R., Freedman J., et al. A survey of red cell use in 45 hospitals in central Ontario, Canada. Transfusion 1996, 36:699-706.
2. Wang X., Zheng Z., Ao H., et al. A comparison before and after aprotinin was suspended in cardiac surgery: Different results in the real world from a single cardiac center in China. J Thorac Cardiovasc Surg 2009, 138:897-903.
3. Ferraris V.A., Ferraris V.A., Ferraris S.P., et al. Perioperative blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007, 83:S27-S86.
4. Wu W.C., Rathore S.S., Wang Y., et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001, 345:1230-1236.
5. van Woerkens E.C., Trouwborst A., van Lanschot J.J. Profound hemodilution: What is the critical level of hemodilution at which oxygen delivery-dependent oxygen consumption starts in an anesthetized human?. Anesth Analg 1992, 75:818-821.
6. DeFoe G.R., Ross C.S., Olmstead E.M., et al. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg 2001, 71:769-776.
7. Karkouti K., Djaiani G., Borger M.A., et al. Low hematocrit during cardiopulmonary bypass is associated with increased risk of perioperative stroke in cardiac surgery. Ann Thorac Surg 2005, 80:1381-1387.
8. Weisel R.D., Charlesworth D.C., Mickleborough L.L., et al. Limitations of blood conservation. J Thorac Cardiovasc Surg 1984, 88:26-38.
9. Fang W.C., Helm R.E., Krieger K.H., et al. Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery. Circulation 1997, 96:II-194-II-199.
10. Hebert P.C., Wells G., Blajchman M.A., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999, 340:409-417.
11. Vincent J.L., Baron J.F., Reinhart K., et al. Anemia and blood transfusion in critically ill patients. JAMA 2002, 288:1499-1507.
12. Engoren M.C., Habib R.H., Zacharias A., et al. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 2002, 74:1180-1186.
13. Surgenor S.D., Kramer R.S., Olmstead E.M., et al. The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery. Anesth Analg 2009, 108:1741-1746.
14. Koch C.G., Li L., Duncan A.I., et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 2006, 34:1608-1616.
15. Koch C.G., Li L., Duncan A.I., et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 2006, 81:1650-1657.
16. Surgenor S.D., DeFoe G.R., Fillinger M.P., et al. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure. Circulation 2006, 114:I43-I48.
17. Rebollo M.H., Bernal J.M., Llorca J., et al. Nosocomial infections in patients having cardiovascular operations: A multivariate analysis of risk factors. J Thorac Cardiovasc Surg 1996, 112:908-913.
18. Leal-Noval S.R., Rincón-Ferrari M.D., García-Curiel A., et al. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest 2001, 119:1461-1468.
19. Ferraris V.A., Ferraris S.P., Moliterno D.J., et al. The Society of Thoracic Surgeons practice guideline series: Aspirin and other antiplatelet agents during operative coronary revascularization. Ann Thorac Surg 2005, 79:1454-1461. (executive summary).
20. Grines C.L., Bonow R.O., Casey D.E., et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 2007, 115:813-818.
21. Kincaid E.H., Monroe M.L., Saliba D.L., et al. Effects of preoperative enoxaparin versus unfractionated heparin on bleeding indices in patients undergoing coronary artery bypass grafting. Ann Thorac Surg 2003, 76:124-128. discussion:128.
22. Medalion B., Frenkel G., Patachenko P., et al. Preoperative use of enoxaparin is not a risk factor for postoperative bleeding after coronary artery bypass surgery. J Thorac Cardiovasc Surg 2003, 126:1875-1879.
23. Martin K., Keller E., Gertler R., et al. Efficiency and safety of preoperative autologous blood donation in cardiac surgery: A matched-pair analysis in 432 patients. Eur J Cardiothorac Surg 2010, 37:1396-1401.
24. Koch C.G., Li L., Sessler D.I., et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008, 358:1229-1239.
25. van Straten A.H., Soliman Hamad M.A., Zundert A.A., et al. Effect of duration of red blood cell storage on early and late mortality after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2010.
26. Vamvakas E.C. Meta-analysis of clinical studies of the purported deleterious effects of "old" (versus "fresh") red blood cells: Are we at equipoise?. Transfusion 2010, 50:600-610.
27. Tretiak R., Laupacis A., Riviere M., et al. Cost of allogeneic and autologous blood transfusion in Canada. Canadian Cost of Transfusion Study Group. CMAJ 1996, 154:1501-1508.
28. Laupacis A., Fergusson D. Erythropoietin to minimize perioperative blood transfusion: A systematic review of randomized trials. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Transfus Med 1998, 8:309-317.
29. Yazicioglu L., Eryilmaz S., Sirlak M., et al. Recombinant human erythropoietin administration in cardiac surgery. J Thorac Cardiovasc Surg 2001, 122:741-745.
30. Ngaage D.L., Bland J.M. Lessons from aprotinin: Is the routine use and inconsistent dosing of tranexamic acid prudent?. Meta-analysis of randomised and large matched observational studies. Eur J Cardiothorac Surg 2010, 37:1375-1383.
31. Ramnath A.N., Naber H.R., de Boer A., et al. No benefit of intraoperative whole blood sequestration and autotransfusion during coronary artery bypass grafting: Results of a randomized clinical trial. J Thorac Cardiovasc Surg 2003, 125:1432-1437.
32. Kochamba G.S., Pfeffer T.A., Sintek C.F., et al. Intraoperative autotransfusion reduces blood loss after cardiopulmonary bypass. Ann Thorac Surg 1996, 61:900-903.
33. Licker M., Sierra J., Kalangos A., et al. Cardioprotective effects of acute normovolemic hemodilution in patients with severe aortic stenosis undergoing valve replacement. Transfusion 2007, 47:341-350.
34. Fromes Y., Gaillard D., Ponzio O., et al. Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. Eur J Cardiothorac Surg 2002, 22:527-533.
35. Banbury M.K., White J.A., Blackstone E.H., et al. Mr Vacuum-assisted venous return reduces blood usage. J Thorac Cardiovasc Surg 2003, 126:680-687.
36. Carless P.A., Henry D.A., Moxey A.J., et al. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2010, 4. CD001888.
37. Shroyer A.L., Grover F.L., Hattler B., et al. On-pump versus off-pump coronary-artery bypass surgery. N Engl J Med 2009, 361:1827-1837.
38. Varghese R, Guo LR, Suskin N, et al: Does a liberal transfusion strategy improve functional outcomes and quality of life in older patients undergoing non-emergency cardiac surgery? A Randomized Clinical Trial. J Thorac Cardiovasc Surg, in press.
39. Goodnough L.T., Johnston M.F., Toy P.T. The variability of transfusion practice in coronary artery bypass surgery. Transfusion Medicine Academic Award Group. JAMA 1991, 265:86-90.
40. Stover E.P., Siegel L.C., Parks R., et al. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: A 24-institution study. Institutions of the Multicenter Study of Perioperative Ischemia Research Group. Anesthesiology 1998, 88:327-333.